Is Ipca Laboratories Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Ipca Laboratories Ltd and arrived at the following conclusion.

Is the current market price of Ipca Laboratories Ltd a good price to buy it?

The 5-year analysis of Ipca Laboratories Ltd's performance infers.

What is Ipca Laboratories Ltd share price return in the past 10 years?

We analysed the performance of Ipca Laboratories Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Ipca Laboratories Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Ipca Laboratories Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Ipca Laboratories informs about company updates

Ipca Laboratories Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524494 | NSE: IPCALAB

24 Aug 2019

Evaluate

Ipca Laboratories has informed that the US FDA conducted the inspection of the Company’s Formulations manufacturing Unit situated at Piparia (Silvassa) from 19th August, 2019 to 23rd August, 2019. At the conclusion of the inspection, the US FDA issued a Form 483 with 3 observations.

The above information is a part of company’s filings submitted to BSE.

Related Ipca Laboratories Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News